Colossal Biosciences announces de-extinction of dire wolf
On Apr. 7, 2025, scientists at Colossal Biosciences announced the successful de-extinction of the dire wolf with the…
On Apr. 7, 2025, scientists at Colossal Biosciences announced the successful de-extinction of the dire wolf with the…
On April 3, France’s Université Paris-Saclay said it is one of dozens of European institutions ramping up efforts…
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
On Mar. 4, 2025, Colossal Biosciences announced that its scientists have simultaneously edited seven genes in mice embryos…
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
On Dec. 2, 2024, engineers in the University of Southern Califoronia (USC) Alfred E. Mann Department of Biomedical…
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
On Mar. 21, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…
On Jan 28, 2021, Mammoth Biosciences announced a co-marketing agreement with Agilent Technologies to support the anticipated launch…
On Jan. 14, 2021, Mammoth Biosciences announced that it had secured a subcontract with MRIGlobal, the prime contractor…
On Jan. 11, 2021, Editas Medicine announced the U.S. Food and Drug Administration (FDA) had cleared the initiation…
On Dec.14, 2020, the US Food and Drug Administration (FDA) announced they had granted Investigational New Drug (IND)…
On Dec. 11, 2020, Sanatech Seed Co, and sales partner Pioneer EcoScience, announced the commercial sales of Sicilian…
On Nov. 4, 2020, using the cutting-edge genetic editing technique known as CRISP ‘lab on a chip’ technology,…